Opioid Use Disorder
📧 Sign up to get email alerts when something new happens for Opioid Use Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2009-11-09FDA Approved: METHADOSE DISPERSIBLE — Supplemental Application (SpecGx LLC)
FDA approved a supplemental application for Methadose Dispersible (methadone hydrochloride) from SpecGx LLC, authorizing the dispersible dos…
-
CLINICAL_TRIALS research · 2009-11-05Clinical Trial Update: Ultra-rapid Opiate Detoxification Using Deep Sedation and Prior Oral Buprenorphine Preparation.
This entry describes a clinical trial evaluating ultra-rapid detoxification from opioids using deep sedation with prior oral buprenorphine p…
-
CLINICAL_TRIALS trial_result · 2009-09-16Clinical Trial Update: Safety Study of Intravenous 6β-Naltrexol (AIKO-150) in Opioid-Dependent Subjects [Phase 1]
A Phase 1 safety study of intravenous 6β-naltrexol (AIKO-150) in individuals with opioid use disorder has completed.
-
CLINICAL_TRIALS trial_result · 2009-07-07Clinical Trial Update: Buprenorphine as a Treatment in Opiate Dependent Pain Patients [Phase 4]
A Phase 4 trial evaluating buprenorphine for patients with opioid use disorder and refractory pain was terminated, with results posted in 20…
-
CLINICAL_TRIALS research · 2009-06-02Clinical Trial Update: Attitudes Towards Buprenorphine and Methadone
An update on a clinical trial examining attitudes toward buprenorphine and methadone in individuals with opioid use disorder.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2009-05-05Clinical Trial Update: Naltrexone Implants as an Aid in Preventing Relapse Following Inpatient Treatment for Opioid Addiction [Phase 2, Phase 3]
Phase 2/3 clinical trials evaluating naltrexone implants to prevent relapse after inpatient treatment for opioid dependence have been comple…
-
CLINICAL_TRIALS trial_result · 2009-03-20Clinical Trial Update: Lofexidine for Inpatient Opiate Detox [Phase 3]
A Phase 3 trial of lofexidine for inpatient detoxification in opioid use disorder has completed.
-
CLINICAL_TRIALS trial_result · 2009-01-27Clinical Trial Update: Examination of Cognitive Function in Patients Treated With Subutex
This completed clinical trial examined cognitive function in patients treated with Subutex (buprenorphine) for opioid use disorder.
-
CLINICAL_TRIALS trial_result · 2009-01-21Clinical Trial Update: Effect Of Case Management Following Discharge From Methadone Treatment [Phase 2]
Phase 2 clinical trial update evaluating case management after discharge from methadone treatment for opioid use disorder; the trial status …
-
CLINICAL_TRIALS trial_result · 2009-01-21Clinical Trial Update: Determine the Safety of a Sublingual Tablet Formulation of Buprenorphine and Naloxone by Extending the Combination Tablet Availability to Physicians in Office-Based Practice [Phase 4]
This Phase 4 study evaluated the safety of a buprenorphine/naloxone sublingual tablet and examined extending its availability to physicians …
-
CLINICAL_TRIALS trial_result · 2008-11-20Clinical Trial Update: Temporal Discounting Delayed Outcomes on Opioid-Dependent Outpatients - 20 [Phase 2]
Phase 2 clinical trial assessing temporal discounting of delayed outcomes in opioid-dependent outpatients; the study has completed.
-
CLINICAL_TRIALS trial_result · 2008-09-10Clinical Trial Update: Transfer From Methadone to Buprenorphine Maintenance Treatment Using Buprenorphine Patches [Phase 4]
Clinical trial exploring transfer from methadone to buprenorphine maintenance using buprenorphine patches in Phase 4 for opioid use disorder…
-
CLINICAL_TRIALS research · 2008-08-13Clinical Trial Update: Applying Web Technology to Buprenorphine Treatment [NA]
This clinical trial update discusses applying web technology to support buprenorphine treatment for adults with opioid use disorder. The sta…
-
CLINICAL_TRIALS trial_result · 2008-08-12Clinical Trial Update: Science-Based Treatment for Opioid-Dependent Adolescents [Phase 2]
A Phase 2 clinical trial update evaluating science-based treatment for opioid use disorder in adolescents; the current status is UNKNOWN.
-
CLINICAL_TRIALS trial_result · 2008-08-01Clinical Trial Update: Ability of Aprepitant to Block Opioid Reward in Non-Dependent Opiate Abusers [Phase 1]
Phase 1 study exploring whether the NK1 receptor antagonist aprepitant can block opioid reward in non-dependent opiate abusers.
-
CLINICAL_TRIALS trial_result · 2008-03-28Clinical Trial Update: HEPMET-1: Evaluate the Feasibility, Mental Sideeffects and the Efficacy of Hepatitis C Treatment in a MMT Group. [Phase 3]
The HEPMET-1 Phase 3 trial evaluated feasibility, mental side effects, and efficacy of Hepatitis C treatment in patients on methadone mainte…
-
FDA approval · 2008-01-26FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (SpecGx LLC)
FDA approved a supplemental application for methadone hydrochloride from SpecGx LLC, enabling another generic version of the product.
-
FDA approval · 2008-01-14FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Methadone Hydrochloride submitted by Hikma Pharmaceuticals USA Inc.
-
FDA approval · 2008-01-02FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for methadone hydrochloride from Hikma Pharmaceuticals USA Inc., authorizing changes included in…
-
FDA approval · 2008-01-02FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for methadone hydrochloride (generic) submitted by Hikma Pharmaceuticals USA Inc.
-
FDA approval · 2007-12-14FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (VistaPharm, LLC)
FDA approved a supplemental application for Methadone Hydrochloride from VistaPharm, LLC, resulting in a supplemental approval for this gene…
-
FDA approval · 2007-10-26FDA Approved: VIVITROL — Supplemental Application (Alkermes, Inc.)
FDA approved a supplemental application for VIVITROL (naltrexone) from Alkermes, Inc.
-
FDA approval · 2007-06-07FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for generic methadone hydrochloride from Hikma Pharmaceuticals USA Inc.
-
FDA approval · 2007-06-07FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Methadone Hydrochloride from Hikma Pharmaceuticals USA Inc., indicating approval of a generic pr…
-
FDA approval · 2007-05-09FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for methadone hydrochloride, a generic product manufactured by Hikma Pharmaceuticals USA Inc., u…